An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
Clinical trial NCT00677313 · COMPLETED
Trial details
- NCT number
- NCT00677313
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2015-01-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.